Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors.

European Journal of Medicinal Chemistry
Chau Phi DinhDenis Séraphin

Abstract

Inflammation contributes to the development of various pathologies, e.g. asthma, cardiovascular diseases, some types of cancer, and metabolic disorders. Leukotrienes (LT), biosynthesized from arachidonic acid by 5-lipoxygenase (5-LO), constitute a potent family of pro-inflammatory lipid mediators. δ-Garcinoic acid (δ-GA) (1), a natural vitamin E analogue, was chosen for further structural optimization as it selectively inhibited 5-LO activity in cell-free and cell-based assays without impairing the production of specialized pro-resolving mediators by 15-LO. A model of semi-quantitative prediction of 5-LO inhibitory potential developed during the current study allowed the design of 24 garcinamides that were semi-synthesized. In accordance with the prediction model, biological evaluations showed that eight compounds potently inhibited human recombinant 5-LO (IC50 < 100 nM). Interestingly, four compounds were substantially more potent than 1 in activated primary human neutrophils assays. Structure - activity relationships shed light on a supplementary hydrophobic pocket in the allosteric binding site that could be fitted with an aromatic ring.

References

Nov 30, 1964·Biochemical and Biophysical Research Communications·J F PennockJ D Kerr
Mar 6, 2003·The Journal of Allergy and Clinical Immunology·William W Busse, Lanny J Rosenwasser
Aug 12, 2003·Proteins·Marcel L VerdonkRichard D Taylor
Jan 26, 2005·Journal of Chemical Information and Modeling·Gerhard Wolber, Thierry Langer
Apr 22, 2005·The New England Journal of Medicine·Göran K Hansson
Jul 14, 2006·Pharmacology & Therapeutics·Oliver Werz, Dieter Steinhilber
Dec 15, 2006·Nature·Gökhan S Hotamisligil
Apr 22, 2008·Current Opinion in Chemical Biology·A Ganesan
Jul 25, 2008·Nature·Ruslan Medzhitov
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Sep 26, 2008·BMC Bioinformatics·David LagorceBruno O Villoutreix
Jan 8, 2009·Journal of Chemical Information and Modeling·Oliver KorbThomas E Exner
Jan 27, 2009·Chemical Society Reviews·Eric Valeur, Mark Bradley
Feb 26, 2010·Expert Opinion on Therapeutic Patents·Carlo Pergola, Oliver Werz
Jan 15, 2011·Science·Nathaniel C GilbertMarcia E Newcomer
Aug 26, 2014·Biochimica Et Biophysica Acta·Olof RådmarkBengt Samuelsson
Mar 17, 2016·World Journal of Biological Chemistry·Lisa SchmölzMaria Wallert
Apr 14, 2016·Monatshefte für chemie·Birgit WaltenbergerHermann Stuppner
Jun 11, 2016·Planta medica·Khaled AlsabilPascal Richomme
Nov 7, 2016·Free Radical Biology & Medicine·Francesco GalliNesrin Kartal Özer
Sep 22, 2018·Nature Communications·Helmut PeinAndreas Koeberle
Jan 11, 2019·Journal of Natural Products·Alexia VilleDenis Séraphin
Mar 12, 2020·Journal of Medicinal Chemistry·Desirée BartoliniFrancesco Galli

❮ Previous
Next ❯

Citations

Oct 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Audrey Isabel ChiassonMohamed Touaibia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.